Compounds > 2-hexynyladenosine-5'-n-ethylcarboxamide
Page last updated: 2024-09-05

2-hexynyladenosine-5'-n-ethylcarboxamide and oxidopamine

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Trials
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Recent Studies (post-2010)
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Studies
(oxidopamine)		Trials
(oxidopamine)		Recent Studies (post-2010) (oxidopamine)
28028,63062,407

Protein Interaction Comparison

ProteinTaxonomy2-hexynyladenosine-5'-n-ethylcarboxamide (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cristalli, G; Morelli, M; Pinna, A; Wardas, J1

Other Studies

1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and oxidopamine

ArticleYear
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
    Brain research, 1997, Jun-06, Volume: 759, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dopamine Agonists; Immunohistochemistry; Limbic System; Male; Oxidopamine; Phenethylamines; Proto-Oncogene Proteins c-fos; Purinergic Antagonists; Purinergic P1 Receptor Agonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Triazoles

1997